For me H1 points to the FY at the top end of the expected range.
Good result and as always building up the big R&D cash warchest.
- Forums
- ASX - By Stock
- Ann: Half Year Results Announcement
For me H1 points to the FY at the top end of the expected...
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$297.90 |
Change
3.000(1.02%) |
Mkt cap ! $142.5B |
Open | High | Low | Value | Volume |
$297.44 | $299.00 | $297.16 | $59.91M | 201.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $297.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$297.95 | 38 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 560 | 298.000 |
1 | 6 | 297.970 |
1 | 25 | 297.940 |
1 | 54 | 297.930 |
1 | 54 | 297.920 |
Price($) | Vol. | No. |
---|---|---|
298.030 | 1 | 1 |
298.050 | 27 | 1 |
298.070 | 25 | 1 |
298.080 | 14 | 2 |
298.090 | 4 | 1 |
Last trade - 12.06pm 04/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online